Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Shareholders
Sort By
Newest First
Sign in
1 / 1
1 / 1
Generics
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Mallinckrodt Pharmaceuticals
PR-M05-19-NI-087
May 31, 2019
Response
Allergan Responds to Public Shareholder Letter
Allergan, plc
PR-M02-19-NI-047
Feb 21, 2019
